We are live on
!
Find out more
RWJF
Robert Wood Johnson Foundation Portfolio holdings
AUM
$81M
1-Year Est. Return
0.47%
This Fund
S&P 500
This Quarter
Est. Return
-9.9%
1 Year Est. Return
+0.47%
3 Year Est. Return
-4.83%
5 Year Est. Return
-4.4%
10 Year Est. Return
-8.06%
AUM
$19.6B
AUM Growth
+$10.5B
(+115%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-0.89%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DADA
Dada Nexus
DADA
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 39.33% |
| 2 | Healthcare | 32.32% |
| 3 | Financials | 28.35% |
Similar funds
RCI
CLP
PA
RC
LTM
NVIM
MM
BG
Robert Wood Johnson Foundation's Q1 2021 Portfolio in Review
As of Q1 2021, Robert Wood Johnson Foundation held 4 positions worth $19.6B, up 115% from $9.14B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Robert Wood Johnson Foundation's Q1 2021 filing shows 1 new and 2 reduced positions. Its largest new stake was Dada Nexus: 28,402 shares worth $7.71B. The largest sale was Royalty Pharma, an estimated $142M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 39% of assets, followed by Healthcare and Financials.
- Robert Wood Johnson Foundation's largest Q1 2021 buy was Dada Nexus: 28,402 shares worth $7.71B.
- Robert Wood Johnson Foundation's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $142M.
- Robert Wood Johnson Foundation's ten largest holdings make up 100% of its $19.6B portfolio in Q1 2021.
- Robert Wood Johnson Foundation opened 1 new position and closed 0 in Q1 2021.
- Robert Wood Johnson Foundation's portfolio value rose 115% quarter-over-quarter to $19.6B.
Based on Robert Wood Johnson Foundation's 13F filing for Q1 2021, filed 10 May 2021.